STOCK TITAN

[Form 4] Integra LifeSciences Holdings Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Form 4 filing summary – KeyCorp (KEY), 07/01/2025: Director Barbara R. Snyder converted 35,955 deferred shares (transaction code M) into an equal number of common shares. The conversion increased her directly held common-share position to 71,632 shares. No open-market purchase or sale price was reported because the shares derive from KeyCorp’s Directors’ Deferred Share Sub-Plan, where each deferred share is economically equivalent to a common share. Following the transaction, Snyder still holds 177,901 deferred shares that remain subject to the plan. The filing also notes that direct ownership totals include roughly 175 common shares obtained through the June 2025 dividend-reinvestment program, and deferred-share holdings include about 2,765 dividend-equivalent units accrued during the same period. As there was no disposition of shares and the transaction merely settles a long-standing equity award, the impact on KeyCorp’s public float and insider sentiment is modest.

Riepilogo deposito Modulo 4 – KeyCorp (KEY), 01/07/2025: La direttrice Barbara R. Snyder ha convertito 35.955 azioni differite (codice transazione M) in un numero equivalente di azioni ordinarie. La conversione ha aumentato la sua posizione direttamente detenuta in azioni ordinarie a 71.632 azioni. Non è stato riportato alcun prezzo di acquisto o vendita sul mercato aperto poiché le azioni derivano dal Sotto-Piano di Azioni Differite per i Direttori di KeyCorp, dove ogni azione differita è economicamente equivalente a un'azione ordinaria. Dopo la transazione, Snyder detiene ancora 177.901 azioni differite soggette al piano. Il deposito segnala inoltre che il totale della proprietà diretta include circa 175 azioni ordinarie ottenute tramite il programma di reinvestimento dei dividendi di giugno 2025, mentre le azioni differite comprendono circa 2.765 unità equivalenti a dividendi maturate nello stesso periodo. Poiché non vi è stata alcuna cessione di azioni e la transazione si limita a regolare un premio azionario di lunga data, l'impatto sulla flottante pubblica di KeyCorp e sul sentiment degli insider è modesto.

Resumen de presentación del Formulario 4 – KeyCorp (KEY), 01/07/2025: La directora Barbara R. Snyder convirtió 35,955 acciones diferidas (código de transacción M) en un número igual de acciones comunes. La conversión aumentó su posición de acciones comunes poseídas directamente a 71,632 acciones. No se reportó precio de compra o venta en mercado abierto porque las acciones provienen del Subplan de Acciones Diferidas para Directores de KeyCorp, donde cada acción diferida es económicamente equivalente a una acción común. Tras la transacción, Snyder aún posee 177,901 acciones diferidas que permanecen sujetas al plan. La presentación también señala que la propiedad directa total incluye aproximadamente 175 acciones comunes obtenidas a través del programa de reinversión de dividendos de junio de 2025, y las acciones diferidas incluyen alrededor de 2,765 unidades equivalentes a dividendos acumuladas durante el mismo período. Dado que no hubo disposición de acciones y la transacción simplemente liquida un premio de acciones de larga data, el impacto en el flotante público de KeyCorp y el sentimiento de los insiders es modesto.

양식 4 제출 요약 – KeyCorp (KEY), 2025년 7월 1일: 이사 Barbara R. Snyder가 35,955개의 이연 주식(거래 코드 M)을 동일 수량의 보통주로 전환했습니다. 이 전환으로 그녀가 직접 보유한 보통주 수는 71,632주로 증가했습니다. 이 주식들은 KeyCorp 이사 이연 주식 하위 계획에서 나온 것으로, 각 이연 주식은 경제적으로 보통주와 동일하므로 공개 시장에서의 매입 또는 매도 가격은 보고되지 않았습니다. 거래 후 Snyder는 여전히 177,901주의 이연 주식을 보유하고 있으며, 이는 계획에 따라 유지되고 있습니다. 제출서에는 직접 소유 총계에 2025년 6월 배당금 재투자 프로그램을 통해 취득한 약 175주의 보통주가 포함되어 있고, 이연 주식 보유에는 같은 기간 동안 발생한 약 2,765개의 배당금 상당 단위가 포함되어 있다고 명시되어 있습니다. 주식 처분이 없었고 이번 거래는 장기 주식 보상을 단순히 정산하는 것이므로 KeyCorp의 공개 유통 주식 수와 내부자 심리에 미치는 영향은 미미합니다.

Résumé du dépôt du formulaire 4 – KeyCorp (KEY), 01/07/2025 : La directrice Barbara R. Snyder a converti 35 955 actions différées (code de transaction M) en un nombre égal d’actions ordinaires. Cette conversion a porté sa position d’actions ordinaires directement détenues à 71 632 actions. Aucun prix d’achat ou de vente sur le marché ouvert n’a été déclaré, car ces actions proviennent du sous-plan d’actions différées des administrateurs de KeyCorp, où chaque action différée est économiquement équivalente à une action ordinaire. Suite à cette transaction, Snyder détient toujours 177 901 actions différées soumises au plan. Le dépôt précise également que la propriété directe totale comprend environ 175 actions ordinaires obtenues via le programme de réinvestissement des dividendes de juin 2025, et que les avoirs en actions différées incluent environ 2 765 unités équivalentes en dividendes accumulées durant la même période. Comme il n’y a eu aucune cession d’actions et que la transaction ne fait que régler une attribution d’actions ancienne, l’impact sur le flottant public de KeyCorp et le sentiment des initiés est modéré.

Formular 4 Einreichungszusammenfassung – KeyCorp (KEY), 01.07.2025: Direktorin Barbara R. Snyder hat 35.955 aufgeschobene Aktien (Transaktionscode M) in die gleiche Anzahl von Stammaktien umgewandelt. Durch die Umwandlung erhöhte sich ihre direkt gehaltene Stammaktienposition auf 71.632 Aktien. Es wurde kein Kauf- oder Verkaufspreis am offenen Markt gemeldet, da die Aktien aus dem Directors’ Deferred Share Sub-Plan von KeyCorp stammen, bei dem jede aufgeschobene Aktie wirtschaftlich einer Stammaktie entspricht. Nach der Transaktion hält Snyder weiterhin 177.901 aufgeschobene Aktien, die dem Plan unterliegen. Die Einreichung weist zudem darauf hin, dass die Gesamtzahl der Direktbesitze etwa 175 Stammaktien umfasst, die durch das Dividenden-Reinvestitionsprogramm im Juni 2025 erworben wurden, und dass die Bestände an aufgeschobenen Aktien etwa 2.765 dividendenäquivalente Einheiten umfassen, die im gleichen Zeitraum angesammelt wurden. Da es keinen Verkauf von Aktien gab und die Transaktion lediglich eine langjährige Aktienzuwendung abwickelt, ist die Auswirkung auf den öffentlichen Streubesitz von KeyCorp und die Insider-Stimmung gering.

Positive
  • Director’s direct ownership increased from roughly 36k to 71.6k shares, modestly aligning insider and shareholder interests.
  • No shares were sold; the transaction does not indicate insider profit-taking.
Negative
  • None.

Insights

TL;DR: Director converted 35.9k deferred shares to common; no sales, marginal positive signal.

The M-code conversion reflects routine settlement of director compensation rather than an opportunistic purchase. Nonetheless, Snyder’s direct stake nearly doubled to 71.6k shares, aligning her incentives more closely with shareholders. Because the shares originate from a deferred-comp plan, no cash outlay occurred and there is no dilution; the shares were already included in fully diluted counts. From a trading-signal perspective, the absence of sales and increased direct ownership is slightly constructive but not a catalyst. Overall impact: neutral-to-slightly-positive.

TL;DR: Routine equity-award settlement; governance implications minimal.

KeyCorp’s board compensation plan continues to shift equity from deferred units to outright ownership, improving transparency of insider stakes. Such conversions comply with the 2019 Equity Compensation Plan and show ongoing alignment without raising pay-for-performance concerns. No red flags regarding trading plans or Rule 10b5-1 usage are indicated. Therefore, the governance impact is neutral; investors should not expect strategy changes or signaling effects from this filing.

Riepilogo deposito Modulo 4 – KeyCorp (KEY), 01/07/2025: La direttrice Barbara R. Snyder ha convertito 35.955 azioni differite (codice transazione M) in un numero equivalente di azioni ordinarie. La conversione ha aumentato la sua posizione direttamente detenuta in azioni ordinarie a 71.632 azioni. Non è stato riportato alcun prezzo di acquisto o vendita sul mercato aperto poiché le azioni derivano dal Sotto-Piano di Azioni Differite per i Direttori di KeyCorp, dove ogni azione differita è economicamente equivalente a un'azione ordinaria. Dopo la transazione, Snyder detiene ancora 177.901 azioni differite soggette al piano. Il deposito segnala inoltre che il totale della proprietà diretta include circa 175 azioni ordinarie ottenute tramite il programma di reinvestimento dei dividendi di giugno 2025, mentre le azioni differite comprendono circa 2.765 unità equivalenti a dividendi maturate nello stesso periodo. Poiché non vi è stata alcuna cessione di azioni e la transazione si limita a regolare un premio azionario di lunga data, l'impatto sulla flottante pubblica di KeyCorp e sul sentiment degli insider è modesto.

Resumen de presentación del Formulario 4 – KeyCorp (KEY), 01/07/2025: La directora Barbara R. Snyder convirtió 35,955 acciones diferidas (código de transacción M) en un número igual de acciones comunes. La conversión aumentó su posición de acciones comunes poseídas directamente a 71,632 acciones. No se reportó precio de compra o venta en mercado abierto porque las acciones provienen del Subplan de Acciones Diferidas para Directores de KeyCorp, donde cada acción diferida es económicamente equivalente a una acción común. Tras la transacción, Snyder aún posee 177,901 acciones diferidas que permanecen sujetas al plan. La presentación también señala que la propiedad directa total incluye aproximadamente 175 acciones comunes obtenidas a través del programa de reinversión de dividendos de junio de 2025, y las acciones diferidas incluyen alrededor de 2,765 unidades equivalentes a dividendos acumuladas durante el mismo período. Dado que no hubo disposición de acciones y la transacción simplemente liquida un premio de acciones de larga data, el impacto en el flotante público de KeyCorp y el sentimiento de los insiders es modesto.

양식 4 제출 요약 – KeyCorp (KEY), 2025년 7월 1일: 이사 Barbara R. Snyder가 35,955개의 이연 주식(거래 코드 M)을 동일 수량의 보통주로 전환했습니다. 이 전환으로 그녀가 직접 보유한 보통주 수는 71,632주로 증가했습니다. 이 주식들은 KeyCorp 이사 이연 주식 하위 계획에서 나온 것으로, 각 이연 주식은 경제적으로 보통주와 동일하므로 공개 시장에서의 매입 또는 매도 가격은 보고되지 않았습니다. 거래 후 Snyder는 여전히 177,901주의 이연 주식을 보유하고 있으며, 이는 계획에 따라 유지되고 있습니다. 제출서에는 직접 소유 총계에 2025년 6월 배당금 재투자 프로그램을 통해 취득한 약 175주의 보통주가 포함되어 있고, 이연 주식 보유에는 같은 기간 동안 발생한 약 2,765개의 배당금 상당 단위가 포함되어 있다고 명시되어 있습니다. 주식 처분이 없었고 이번 거래는 장기 주식 보상을 단순히 정산하는 것이므로 KeyCorp의 공개 유통 주식 수와 내부자 심리에 미치는 영향은 미미합니다.

Résumé du dépôt du formulaire 4 – KeyCorp (KEY), 01/07/2025 : La directrice Barbara R. Snyder a converti 35 955 actions différées (code de transaction M) en un nombre égal d’actions ordinaires. Cette conversion a porté sa position d’actions ordinaires directement détenues à 71 632 actions. Aucun prix d’achat ou de vente sur le marché ouvert n’a été déclaré, car ces actions proviennent du sous-plan d’actions différées des administrateurs de KeyCorp, où chaque action différée est économiquement équivalente à une action ordinaire. Suite à cette transaction, Snyder détient toujours 177 901 actions différées soumises au plan. Le dépôt précise également que la propriété directe totale comprend environ 175 actions ordinaires obtenues via le programme de réinvestissement des dividendes de juin 2025, et que les avoirs en actions différées incluent environ 2 765 unités équivalentes en dividendes accumulées durant la même période. Comme il n’y a eu aucune cession d’actions et que la transaction ne fait que régler une attribution d’actions ancienne, l’impact sur le flottant public de KeyCorp et le sentiment des initiés est modéré.

Formular 4 Einreichungszusammenfassung – KeyCorp (KEY), 01.07.2025: Direktorin Barbara R. Snyder hat 35.955 aufgeschobene Aktien (Transaktionscode M) in die gleiche Anzahl von Stammaktien umgewandelt. Durch die Umwandlung erhöhte sich ihre direkt gehaltene Stammaktienposition auf 71.632 Aktien. Es wurde kein Kauf- oder Verkaufspreis am offenen Markt gemeldet, da die Aktien aus dem Directors’ Deferred Share Sub-Plan von KeyCorp stammen, bei dem jede aufgeschobene Aktie wirtschaftlich einer Stammaktie entspricht. Nach der Transaktion hält Snyder weiterhin 177.901 aufgeschobene Aktien, die dem Plan unterliegen. Die Einreichung weist zudem darauf hin, dass die Gesamtzahl der Direktbesitze etwa 175 Stammaktien umfasst, die durch das Dividenden-Reinvestitionsprogramm im Juni 2025 erworben wurden, und dass die Bestände an aufgeschobenen Aktien etwa 2.765 dividendenäquivalente Einheiten umfassen, die im gleichen Zeitraum angesammelt wurden. Da es keinen Verkauf von Aktien gab und die Transaktion lediglich eine langjährige Aktienzuwendung abwickelt, ist die Auswirkung auf den öffentlichen Streubesitz von KeyCorp und die Insider-Stimmung gering.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Mosebrook Jeffrey

(Last) (First) (Middle)
1100 CAMPUS ROAD

(Street)
PRINCETON NJ 08540

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
INTEGRA LIFESCIENCES HOLDINGS CORP [ IART ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, Fin & Princ Acct Officer
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/01/2025 F 937 D $13.25 39,945 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Lesha Shinn; Attorney-in-Fact 07/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many KeyCorp shares did Director Barbara R. Snyder acquire on 07/01/2025?

She converted 35,955 deferred shares into the same number of common shares.

What is Snyder’s total direct ownership in KEY after the transaction?

Her direct holdings rose to 71,632 common shares.

Did the filing include any open-market sales of KeyCorp stock?

No; the Form 4 shows only an M-code conversion with no dispositions.

How many deferred shares does Snyder still hold following the conversion?

She retains 177,901 deferred shares under the Directors’ Deferred Share Sub-Plan.

Does the transaction affect KeyCorp’s share count or cause dilution?

No, the deferred shares were already factored into diluted share calculations; the conversion itself is non-dilutive.
Integra Lifesciences Hldgs Cp

NASDAQ:IART

IART Rankings

IART Latest News

IART Stock Data

948.87M
66.51M
14.24%
91.53%
5.06%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
PRINCETON